Reference Hub: Scientific review of Ibrance and Interstitial Lung Disease risk

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Primary topic reference

Scientific review of Ibrance and Interstitial Lung Disease risk Resource Guide

A focused review of background, context, and source material on this subject.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

MedlinePlus — Trusted Health Information

Reference: MedlinePlus — Trusted Health Information

Authoritative source for clinical, regulatory, and public-health background reading.